Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DEPO-TESTADIOL | Pharmacia & Upjohn | N-017968 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NATESTO | Acerus Pharmaceuticals Corporation | N-205488 RX | 2014-05-28 | 1 products, RLD, RS |
TESTIM | Auxilium Pharmaceuticals | N-021454 RX | 2002-10-31 | 1 products, RLD, RS |
ANDROGEL | BESINS HLTHCARE | N-022309 RX | 2011-04-29 | 1 products, RLD, RS |
VOGELXO | Upsher-Smith Laboratories | N-204399 RX | 2014-06-04 | 2 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TESTOSTERONE CYPIONATE | Slayback Pharma | N-216318 PEND | 2022-06-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
XYOSTED (AUTOINJECTOR) | Antares Pharma | N-209863 RX | 2018-09-28 | 3 products, RLD, RS |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
breast neoplasms | EFO_0003869 | D001943 | C50 |
delayed puberty | HP_0000823 | D011628 | E30.0 |
hypogonadism | HP_0000044 | D007006 | E23.0 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Testosterone Cypionate, Testosterone Cypionate, Slayback Pharma Llc | |||
11311554 | 2039-03-25 | DP | |
11642355 | 2039-03-25 | DP | |
Testosterone Enanthate, Xyosted (Autoinjector), Antares Pharma Inc | |||
10646495 | 2038-08-30 | DP | |
9950125 | 2036-09-04 | DP | U-2418 |
9744302 | 2035-11-19 | DP | |
11191908 | 2035-10-18 | DP | |
11813435 | 2035-02-25 | DP | |
10238662 | 2035-02-19 | DP | U-2418 |
10912782 | 2035-02-19 | DP | U-2418 |
11160751 | 2034-10-07 | DP | U-2418 |
10881798 | 2034-02-11 | DP | |
10821072 | 2033-06-04 | DP | U-2418 |
11844804 | 2033-06-04 | U-2418 | |
10357609 | 2031-08-21 | DP | |
10905827 | 2031-08-21 | DP | |
11446440 | 2031-08-21 | DP | |
10279131 | 2031-07-31 | DP | |
11497753 | 2030-03-19 | DP | |
8021335 | 2026-10-04 | DP | |
8562564 | 2026-01-24 | DP | |
9180259 | 2026-01-24 | DP | |
9533102 | 2026-01-24 | DP | |
9629959 | 2026-01-24 | DP | |
10478560 | 2026-01-24 | DP | |
11446441 | 2026-01-24 | DP | |
Testosterone, Natesto, Acerus | |||
11090312 | 2034-03-17 | U-1616 | |
8574622 | 2024-02-04 | DP | |
8784869 | 2024-02-04 | DP | |
8784882 | 2024-02-04 | DP | U-1557 |
8877230 | 2024-02-04 | U-1616 | |
Testosterone, Vogelxo, Upsher Smith Labs | |||
8785426 | 2034-02-11 | DP | U-1531 |
9295675 | 2034-02-11 | DP | U-1531 |
9662340 | 2034-02-11 | DP | U-1531 |
Testosterone, Axiron, Eli Lilly And Co | |||
8435944 | 2027-09-27 | U-1390 | |
8419307 | 2027-02-26 | U-1386 | |
8807861 | 2027-02-26 | DP | U-1563 |
9289586 | 2027-02-26 | U-1390 | |
8993520 | 2026-06-02 | U-1390 | |
9180194 | 2026-06-02 | U-1390 | |
Testosterone, Androgel, Besins Hlthcare | |||
8466136 | 2026-10-12 | DP | |
8466137 | 2026-10-12 | U-1103 | |
8466138 | 2026-10-12 | U-1103 | |
8486925 | 2026-10-12 | DP | |
8729057 | 2026-10-12 | DP | |
8741881 | 2026-10-12 | U-1103 | |
8754070 | 2026-10-12 | DP | |
8759329 | 2026-10-12 | DP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypogonadism | D007006 | HP_0000044 | E23.0 | 27 | 56 | 41 | 39 | 35 | 190 |
Prostatic neoplasms | D011471 | — | C61 | 14 | 45 | 17 | 4 | 21 | 96 |
Eunuchism | D005058 | EFO_0007266 | E29.1 | 5 | 10 | 11 | 9 | 8 | 42 |
Healthy volunteers/patients | — | — | — | 12 | 7 | 2 | 3 | 6 | 28 |
Obesity | D009765 | EFO_0001073 | E66.9 | 3 | 4 | 2 | 3 | 11 | 22 |
Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 6 | 3 | — | 1 | 12 | 22 |
Psychological sexual dysfunctions | D020018 | — | F52.0 | 1 | 3 | 12 | 1 | 2 | 19 |
Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | 2 | 2 | 2 | 7 | 4 | 17 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 2 | 3 | 4 | 3 | 5 | 15 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | 4 | 1 | 7 | 3 | 14 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Castration-resistant prostatic neoplasms | D064129 | — | — | 2 | 9 | 1 | — | 1 | 13 |
Adenocarcinoma | D000230 | — | — | 1 | 8 | 2 | — | — | 11 |
Infertility | D007246 | HP_0000789 | — | 3 | 2 | 3 | — | 5 | 11 |
Spinal cord injuries | D013119 | EFO_1001919 | — | 1 | 7 | 2 | — | 2 | 9 |
Male infertility | D007248 | EFO_0004248 | N46 | 1 | 1 | 2 | — | 4 | 8 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 4 | 1 | — | 2 | 8 |
Neoplasms | D009369 | — | C80 | — | 3 | 2 | — | 2 | 7 |
Hemorrhoids | D006484 | EFO_0009552 | K64 | — | 1 | 1 | — | 6 | 7 |
Mobility limitation | D051346 | HP_0002355 | — | — | 1 | 1 | — | 3 | 5 |
Hip fractures | D006620 | EFO_0003964 | S72.00 | — | 2 | 2 | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Contraception | D003267 | — | — | 8 | 6 | — | — | 1 | 12 |
Insulin resistance | D007333 | HP_0000855 | E88.819 | 2 | 3 | — | — | 6 | 10 |
Depression | D003863 | — | F33.9 | — | 2 | — | — | 6 | 8 |
Hyperandrogenism | D017588 | — | — | — | 2 | — | — | 5 | 7 |
Androgen-insensitivity syndrome | D013734 | — | E34.5 | 1 | 3 | — | — | 4 | 7 |
Gonadal disorders | D006058 | — | — | 1 | 3 | — | — | 2 | 5 |
Gender identity | D005783 | — | — | 1 | 1 | — | — | 3 | 4 |
Opioid-related disorders | D009293 | EFO_0005611 | F11 | 1 | 2 | — | — | 1 | 3 |
Primary ovarian insufficiency | D016649 | EFO_0004266 | E28.3 | 1 | 2 | — | — | 1 | 3 |
Colorectal neoplasms | D015179 | — | — | 1 | 1 | — | — | 2 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 2 | — | — | — | 3 | 5 |
Hiv | D006678 | — | O98.7 | 1 | — | — | — | 1 | 2 |
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Peanut hypersensitivity | D021183 | EFO_0007425 | — | 2 | — | — | — | — | 2 |
Head and neck neoplasms | D006258 | — | — | 1 | — | — | — | 1 | 2 |
Facioscapulohumeral muscular dystrophy | D020391 | EFO_0000491 | G71.02 | 1 | — | — | — | — | 1 |
Cerebral arterial diseases | D002539 | EFO_1000859 | — | 1 | — | — | — | — | 1 |
Hyperparathyroidism | D006961 | EFO_0008506 | E21.3 | 1 | — | — | — | — | 1 |
Hypercalcemia | D006934 | HP_0003072 | E83.52 | 1 | — | — | — | — | 1 |
Endocrine bone diseases | D001849 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Blood pressure | D001794 | EFO_0004325 | — | — | — | — | — | 3 | 3 |
Delayed puberty | D011628 | HP_0000823 | E30.0 | — | — | — | — | 3 | 3 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | — | 3 | 3 |
Paresis | D010291 | HP_0001269 | — | — | — | — | — | 3 | 3 |
Acne vulgaris | D000152 | EFO_0003894 | L70 | — | — | — | — | 3 | 3 |
Postoperative pain | D010149 | — | G89.18 | — | — | — | — | 2 | 2 |
Hematologic diseases | D006402 | EFO_0005803 | D75.9 | — | — | — | — | 2 | 2 |
Traumatic brain injuries | D000070642 | — | S06 | — | — | — | — | 2 | 2 |
Appetitive behavior | D001070 | — | — | — | — | — | — | 2 | 2 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | — | — | — | — | 2 | 2 |
Drug common name | Testosterone |
INN | testosterone |
Description | Testosterone is an androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5.. It has a role as an androgen, a human metabolite, a Daphnia magna metabolite and a mouse metabolite. It is a 17beta-hydroxy steroid, an androstanoid, a C19-steroid and a 3-oxo-Delta(4) steroid. |
Classification | Small molecule |
Drug class | steroids (androgens, anabolics); antiandrogens |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O |
PDB | — |
CAS-ID | 58-22-0 |
RxCUI | — |
ChEMBL ID | CHEMBL386630 |
ChEBI ID | 17347 |
PubChem CID | 6013 |
DrugBank | DB00624 |
UNII ID | 3XMK78S47O (ChemIDplus, GSRS) |